MiNK Therapeutics, Inc.
Nasdaq: INKT
- 4 clinical trials, 1 active
- Research grants: $919,500
Life science companies
Explore 35,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Rockwell Medical, Inc.
Nasdaq: RMTI
- Raised $22 million (2018)
- FDA-cleared or approved devices
Sensydia Corp
- Raised $7.8 million (2023)
- 4 clinical trials, 1 active
- Research grants: $5.2 million
- Founded 2015
Cti Biopharma Corp
- Raised $4.1 million (2010)
- 40 clinical trials
- Research grants: $225,000
Advanced Brain Monitoring, Inc.
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $24 million
Alumis Inc.
Nasdaq: ALMS
- Raised $40 million (2024)
- 13 clinical trials, 3 active
- Founded 2021
Amylyx Pharmaceuticals, Inc.
Nasdaq: AMLX
- Raised $30 million (2020)
- 13 clinical trials, 3 active
- Founded 2014
AN2 Therapeutics, Inc.
Nasdaq: ANTX
- Raised $40 million (2026)
- 6 clinical trials
Avm Biotechnology, LLC
- Raised $4.4 million (2021)
- 3 clinical trials, 2 active
- Research grants: $11 million
- Founded 2008
Chemomab Therapeutics Ltd.
Nasdaq: CMMB
- Raised $10 million (2024)
- 6 clinical trials
Eledon Pharmaceuticals, Inc.
Nasdaq: ELDN
- Raised $50 million (2024)
- 6 clinical trials, 3 active
Flint Rehabilitation Devices, LLC
- 6 clinical trials, 1 active
- 1 FDA-registered device site
- Research grants: $33 million
ImageneBio, Inc.
Nasdaq: IMA
- Raised $43 million (2023)
- 6 clinical trials
Inherent Biosciences, Inc.
- Raised $1.5 million (2023)
- 1 clinical trial, 1 active
- Research grants: $5.5 million
- Founded 2019
Insulet Corp
Nasdaq: PODD
- 24 clinical trials, 6 active
- FDA-cleared or approved devices
iVeena Delivery Systems, Inc.
- Raised $2.1 million (2020)
- 3 clinical trials, 2 active
- Research grants: $12 million
- Founded 2014
Nasus Pharma Ltd
NYSE: NSRX
- Raised $15 million (2026)
- 6 clinical trials, 2 active
Olema Pharmaceuticals, Inc.
Nasdaq: OLMA
- Raised $250 million (2024)
- 6 clinical trials, 5 active
BlueWillow Biologics, Inc.
- Raised $850,000 (2024)
- 2 clinical trials
- Research grants: $19 million
- Founded 2006
HemoSonics, LLC
- Raised $15 million (2017)
- 26 clinical trials, 2 active
- Research grants: $7.8 million
Showing 580 of 35,266 companies
Load morePublished company profiles only; counts update daily. Data licences